O1-3-4Clinical outcome of docetaxel plus cisplatin and fluorouracil (DCF) therapy for metastatic esophageal cancer Background: Combination chemotherapy with cisplatin and fluorouracil has been regarded as a standard regimen for patients with metastatic esophageal cancer, but the results of this regimen were unsatisfactory. Previous phase I and II trials showed adding docetaxel to cisplatin and fluorouracil (DCF) therapy improved survivals of patients with metastatic …
